Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Dual action antidepressants and some important considerations.

Ramesh K Gupta1, John W Tiller, Graham D Burrows

  • 1Phillip Health Centre, Woden, Canberra, Australia.

The Australian and New Zealand Journal of Psychiatry
|March 27, 2003
PubMed
Summary

Newer dual-action antidepressants like venlafaxine, mirtazapine, and milnacipran offer improved efficacy and tolerability for major depression relapse prevention compared to older drugs. While generally better tolerated, specific side effects may still occur.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Rhinofacial entomophthoramycosis: A rare fungal infection in an adolescent boy.

Indian journal of pathology & microbiology·2015
Same author

Wine: a scientific exploration.

International journal of psychiatry in clinical practice·2014
Same author

Evaluation of antihepatotoxic potential of Solanum xanthocarpum fruit extract against antitubercular drugs induced hepatopathy in experimental rodents.

Asian Pacific journal of tropical biomedicine·2013
Same author

A critical study of Rasamritam and it's applied aspects.

Ayu·2013
Same author

Nephroprotective activity of Solanum xanthocarpum fruit extract against gentamicin-induced nephrotoxicity and renal dysfunction in experimental rodents.

Asian Pacific journal of tropical medicine·2012
Same author

Hepatoprotective effect of Solanum xanthocarpum fruit extract against CCl4 induced acute liver toxicity in experimental animals.

Asian Pacific journal of tropical medicine·2011

Area of Science:

  • Pharmacology
  • Psychiatry
  • Clinical Medicine

Background:

  • Major depression is a significant global health concern.
  • Long-term management of depression is crucial for preventing relapse.
  • Older antidepressants, like tricyclics, have limitations in efficacy and side effect profiles.

Purpose of the Study:

  • To review controlled studies on long-term treatment with newer dual-action antidepressants.
  • To evaluate the side effects associated with these newer agents.
  • To compare their effectiveness and tolerability against older antidepressant classes.

Main Methods:

  • A comprehensive literature review was conducted using the MedLine database.
  • Studies were selected based on relevance and methodological rigor.

Related Experiment Videos

  • Focus was placed on controlled trials examining long-term outcomes and side effects.

    • Main Results:

    • Three dual-action antidepressants identified: venlafaxine, mirtazapine, and milnacipran.
    • These agents demonstrate superior efficacy and tolerability in treating acute depression and preventing relapse compared to tricyclic antidepressants.
    • Key advantages include a lack of autonomic side effects characteristic of tricyclics.

    Conclusions:

    • Venlafaxine, mirtazapine, and milnacipran represent effective options for long-term depression management.
    • While offering improved tolerability, potential side effects such as sedation, nausea, sexual dysfunction (venlafaxine), and weight gain (mirtazapine) should be monitored.
    • These newer agents provide a valuable alternative for patients with major depression.